Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan · Delayed Price · Currency is JPY 2,212.00
+14.00 (0.64%)
At close: Mar 5, 2026
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 95.29 billion as of March 5, 2026. Its market cap has increased by 0.60% in one year.
Market Cap
95.29B
Enterprise Value
112.20B
Revenue
86.61B
Ranking
n/a
PE Ratio
13.42
Stock Price
2,212.00
Market Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 95.29B, an increase of 63.97%. That is a compound annual growth rate of 1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 94.69B | 2.34% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 261.75B |
| Towa Pharmaceutical | 207.99B |
| Kissei Pharmaceutical | 201.46B |
| Kaken Pharmaceutical | 166.05B |
| Mochida Pharmaceutical | 134.89B |
| KYORIN Pharmaceutical | 97.50B |
| ASKA Pharmaceutical Holdings | 70.51B |
| Fuji Pharma | 57.77B |